Therapy Area
GenFleet and BeiGene partner for Phase Ib/II lymphoma treatment trial
GenFleet will carry out the open-label, single-arm, and multicentre study across ten hospitals in China.
GenFleet will carry out the open-label, single-arm, and multicentre study across ten hospitals in China.